Adage Capital Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Adage Capital Partners’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95M	Hold	1,000,000	–	–	﹤0.01%	872
2026 Q1	$2.46M	Hold	1,000,000	–	–	﹤0.01%	824
2025 Q4	$3.98M	Sell	1,000,000 -2,338,034	-70%	-$10.3M	0.01%	785
2025 Q3	$12.6M	Buy	+3,338,034	New	+$11.3M	0.02%	587
2022 Q3	–	Sell	-900,000	Closed	-$10.2M	–	1076
2022 Q2	$10.2M	Sell	900,000 -500,000	-36%	-$5.99M	0.02%	664
2022 Q1	$22.7M	Hold	1,400,000	–	–	0.04%	416
2021 Q4	$66.3M	Buy	1,400,000 +200,094	+17%	+$12M	0.12%	172
2021 Q3	$87M	Buy	1,199,906 +375,000	+45%	+$27.1M	0.17%	127
2021 Q2	$69.3M	Sell	824,906 -391,788	-32%	-$25.8M	0.14%	161
2021 Q1	$59M	Sell	1,216,694 -187,606	-13%	-$10.2M	0.12%	184
2020 Q4	$66.2M	Buy	1,404,300 +224,228	+19%	+$8.83M	0.14%	157
2020 Q3	$55.5M	Buy	1,180,072 +62,755	+6%	+$2.07M	0.14%	164
2020 Q2	$33.4M	Buy	1,117,317 +117,317	+12%	+$2.43M	0.09%	263
2020 Q1	$13M	Buy	+1,000,000	New	+$12.5M	0.04%	415

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Adage Capital Partners's NBP Position: Q2 2026 in Review

Adage Capital Partners held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q2 2026 at 1,000,000 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #872.

Adage Capital Partners first reported a position in NBP in Q1 2020 and has held it in 14 quarters since. The position peaked at $87M in Q3 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Adage Capital Partners held 1,000,000 shares of NovaBridge Biosciences American Depositary Shares worth $1.95M as of Q2 2026.
Adage Capital Partners left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q2 2026.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Adage Capital Partners's portfolio in Q2 2026, its #872 holding.
Adage Capital Partners first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and has held it in 14 quarters since.
Adage Capital Partners's NovaBridge Biosciences American Depositary Shares position peaked at $87M in Q3 2021.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.